Epstein–Barr Virus/Human Vector Provides High-Level, Long-Term Expression of α1-Antitrypsin in Mice

@article{Stoll2001EpsteinBarrVV,
  title={Epstein–Barr Virus/Human Vector Provides High-Level, Long-Term Expression of $\alpha$1-Antitrypsin in Mice},
  author={Stephanie M Stoll and Christopher R. Sclimenti and Edward J. Baba and Leonard Meuse and Mark A. Kay and Mich{\'e}le P. Calos},
  journal={Molecular Therapy},
  year={2001},
  volume={4},
  pages={122-129}
}
We have constructed plasmid DNA vectors that contain Epstein-Barr virus (EBV) sequences and the human gene (SERPINA1) encoding alpha1-Antitrypsin (AAT). We demonstrate that a plasmid carrying the full SERPINA1 on a 19-kb genomic fragment and the EBV gene EBNA1 and its family of repeats binding sites undergoes efficient extrachromosomal replication in dividing mammalian tissue culture cells. Therefore, use of a whole genomic therapeutic gene to provide both replication and gene expression may be… 

Figures and Tables from this paper

Epstein‐Barr Virus Vectors Provide Prolonged Robust Factor IX Expression in Mice
TLDR
It appears that enhancement of stable hFIX expression by the EBV components was responsible for the increased level and duration of therapeutic gene expression, and the utility of EBV sequences in particular for increasing stable gene expression.
Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA
TLDR
The transfection efficacy of several vectors containing the full genomic hAAT gene with its natural promoter (pTG7101) results in therapeutic and stable concentration of hA AT in plasma, and the important efficacy of nonviral genomic DNA opens a new avenue in the safety applications of human gene therapy.
Robust In Vivo Transduction of a Genetically Stable Epstein-Barr Virus Episome to Hepatocytes in Mice by a Hybrid Viral Vector
TLDR
A hybrid vector that leverages the relative strengths of adenovirus and Epstein-Barr virus is developed and it is demonstrated that this hybrid approach is highly efficient at delivering EBV episomes to target cells in vivo.
A single EBV-based vector for stable episomal maintenance and expression of GFP in human embryonic stem cells.
TLDR
Episomal vectors offer a fast and efficient method to create hESC reporter lines, which in turn allows one to test the effect of overexpression of various genes on stem cell growth, proliferation and differentiation.
Delivery of an EBV episome by a self-circularizing helper-dependent adenovirus: long-term transgene expression in immunocompetent mice
TLDR
This work presents a method for efficient delivery of EBV episomes to nuclei of hepatocytes in living mice using a helper-dependent adenoviral vector and Cre-mediated recombination in vivo to generate circular EBVs episomes following infection.
EXPRESSION OF RECOMBINANT ALPHA-1 ANTITRYPSIN IN CHO AND COS-7 CELL LINES USING LENTIVIRAL VECTOR
TLDR
Large amounts of recombinant human AAT protein were expressed in both CHO and COS-7 cell lines by using a Lentivirus-based gene delivery system that possesses key properties that ensure its application in the delivery of therapeutic genes into mammalian cultured cells.
Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic β-globin in cultured murine fibroblasts
TLDR
These findings illustrate that this oriP/EBNA1-based episomal vector is stable in a previously nonpermissive murine cell line and is a potential vector for human gene therapy.
...
...

References

SHOWING 1-10 OF 46 REFERENCES
Sustained transgene expression in vitro and in vivo using an Epstein–Barr virus replicon vector system combined with HVJ liposomes
TLDR
For long-term gene expression in tissues, an Epstein–Barr virus (EBV) replicon-based plasmid, pEB, containing the latent viral DNA replication origin (oriP) and EBV nuclear antigen-1 (EBNA-1) was constructed and the luciferase gene or lacZ gene was introduced into mouse liver using HVJ–AVE liposomes.
Non-replicating Epstein-Barr Virus-based Plasmids Extend Gene Expression and Can Improve Gene Therapy in Vivo *
TLDR
A gene therapy regimen using non-replicating Epstein-Barr virus (EBV)-based expression plasmids that markedly prolongs gene expression at therapeutic levels and efficiently and repeatedly re-transfects immunocompetent hosts.
Epstein-Barr virus-based vectors that replicate in rodent cells.
Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells
TLDR
It is shown that circular DNAs containing oriP, the EBNA-1 gene and a selectable marker replicate autonomously in cells derived from at at least four developmental lineages and from at least three species.
Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure
TLDR
The results suggest that the hydrodynamics-based transfection procedure provides a valuable tool for screening genes for therapeutic purposes in whole animals.
Gene therapy strategies for treating Epstein-Barr virus-associated lymphomas: comparison of two different Epstein-Barr virus-based vectors.
B cell lymphomas in immunocompromised patients frequently contain the Epstein-Barr virus (EBV) genome (MacMahon et al, 1991), suggesting that gene therapy strategies that target EBV-positive cells
Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein–Barr virus (EBV)-based mini-chromosome vectors in mdx mice
TLDR
Results indicate the potential advantage of EBV-based expression vectors for focal plasmid-mediated gene augmentation therapy in Duchenne muscular dystrophy (DMD) and a range of other gene therapeutic applications.
Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells.
We have constructed an episomal shuttle vector which can transfer large (>100 kb) human genomic DNA inserts back and forth between bacteria and human cells and which can be tracked in rapidly
A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components
TLDR
It is suggested that EBNA-1 interacts with the 30-bp repeated sequence to activate oriP, a genetic element of Epstein-Barr virus that allows those plasmids to replicate and to be maintained in cells that express the Epstein- Barr virus-encoded nuclear antigen EB NA-1.
Up to 100-Fold Increase of Apparent Gene Expression in the Presence of Epstein-Barr Virus oriP Sequences and EBNA1: Implications of the Nuclear Import of Plasmids
TLDR
The data suggest the possibility of substantially increasing the apparent expression of a gene under the control of a strong constitutive promoter in the presence of oriP sequences and EBNA1 in 293 cells.
...
...